COURAGE - Corticosteroid in acute urticaria in emergency department

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-515308-38-00

Acronym

P160913

Enrollment

240

Registered

2024-08-13

Start date

2019-09-21

Completion date

2025-09-17

Last updated

2024-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adults patients with isolated acute urticaria presenting to the emergency department

Brief summary

7-Days Urticaria Activity Score (UAS 7) at day 7

Interventions

DRUGCORTANCYL 20 mg

DRUGcomprimé sécable

DRUGPlacebo of CORTANCYL 20 mg

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
7-Days Urticaria Activity Score (UAS 7) at day 7	—

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026